The Molecular Basis of Transcriptional Activation by the CDP/Cux Transcription Factor

Total Page:16

File Type:pdf, Size:1020Kb

The Molecular Basis of Transcriptional Activation by the CDP/Cux Transcription Factor The Molecular Basis of Transcriptional Activation by the CDP/Cux Transcription Factor Mary Truscott A thesis submitted to the Faculty of Graduate and Post-doctoral Studies in partial fulfillment of the requirements for the degree of Doctor of Philosophy Department of B iochemistry McGill University Montreal, Quebec, Canada August 2006 © Mary Truscott, 2006 Library and Bibliothèque et 1+1 Archives Canada Archives Canada Published Heritage Direction du Branch Patrimoine de l'édition 395 Wellington Street 395, rue Wellington Ottawa ON K1A ON4 Ottawa ON K1A ON4 Canada Canada Your file Votre référence ISBN: 978-0-494-32391-5 Our file Notre référence ISBN: 978-0-494-32391-5 NOTICE: AVIS: The author has granted a non­ L'auteur a accordé une licence non exclusive exclusive license allowing Library permettant à la Bibliothèque et Archives and Archives Canada to reproduce, Canada de reproduire, publier, archiver, publish, archive, preserve, conserve, sauvegarder, conserver, transmettre au public communicate to the public by par télécommunication ou par l'Internet, prêter, telecommunication or on the Internet, distribuer et vendre des thèses partout dans loan, distribute and sell th es es le monde, à des fins commerciales ou autres, worldwide, for commercial or non­ sur support microforme, papier, électronique commercial purposes, in microform, et/ou autres formats. paper, electronic and/or any other formats. The author retains copyright L'auteur conserve la propriété du droit d'auteur ownership and moral rights in et des droits moraux qui protège cette thèse. this thesis. Neither the thesis Ni la thèse ni des extraits substantiels de nor substantial extracts from it celle-ci ne doivent être imprimés ou autrement may be printed or otherwise reproduits sans son autorisation. reproduced without the author's permission. ln compliance with the Canadian Conformément à la loi canadienne Privacy Act some supporting sur la protection de la vie privée, forms may have been removed quelques formulaires secondaires from this thesis. ont été enlevés de cette thèse. While these forms may be included Bien que ces formulaires in the document page count, aient inclus dans la pagination, their removal does not represent il n'y aura aucun contenu manquant. any loss of content from the thesis. ••• Canada Abstract The CDP/Cux transcription factor is expressed as a 200 kDa protein that interacts rapidly and transiently with DNA. Proteolytic processing generates a shorter isoform, pli 0 CDP/Cux, that binds stably to DNA. Processing occurs at the G liS transition of the cell cycle in normal cells, and constitutively in transformed cells. pllO CDP/Cux stimulates cell proliferation by acce1erating entry into S phase. Transgenic mice expressing pli 0 CDP/Cux are more susceptible to different cancers. CDP/Cux was originally described as a repressor of transcription. My goal was to verify whether CDP/Cux might also participate in transcription al activation and characterize the molecu1ar basis for transcriptional activation by CDP/Cux. Using the DNA polymerase a gene promoter as a model system, 1 showed that stimulation of a DNA pol a reporter correlated with DNA binding. Importantly, pllO CDP/Cux stimulated expression from the endogenous DNA pol a promoter. Linker-scanning analysis of the DNA pol a promoter identified a cis-element that was required for p110- mediated activation, yet was not bound by it. 1 determined that E2F1 and E2F2 cooperated with pllO in activating the DNA pol a promoter, and did so via this cis­ element. Furthermore, CDP/Cux recruited these E2Fs to the promoter in chromatin immunoprecipitation experiments. Location array analysis revealed many targets common to p110 and E2Fl. DNA metabolism and cell cycle targets were overrepresented, and further studies showed that pli 0 and E2F cooperated to activate many cell cycle genes. 1 also described a second proteolytic event, which generated an isoform lacking two active repression domains in the C-terminus. Processing was observed in S phase, but not in early G 1, suggesting that processing occurs in proliferating cells. 1 determined that caspases were responsible for this processing, and that this occurs in non-apoptotic conditions. A C-terminally-truncated CDP/Cux protein was a more potent activator of cell cycle-regulated promoters, and accelerated entry of Kit225 T cells into S phase, while uncleavable pllO CDP/Cux proteins were inactive in both assays. These results identified p110 CDP/Cux as a substrate of caspases in proliferating ceIls, and suggested a mechanism by which caspases may accelerate cell cycle progression. 11 Résumé CDPICux est un facteur de transcription de 200 kDa interagissant de façon rapide et transitoire avec l'ADN. Son clivage protéolytique génère une isoforme plus courte, appelée CDPICux pllO, se liant de façon stable à l'ADN. Ce clivage a lieu lors de la transition G 1/S du cycle cellulaire dans les cellules normales, et est constitutif dans les cellules transformées. plI 0 stimule la prolifération cellulaire en accélérant l'entrée en phase S du cycle cellulaire. Ainsi des souris transgéniques exprimant plI 0 sont plus susceptibles de développer différents cancers. CDPICux a originellement été décrit comme un répresseur transcriptionnel. Le but de mon travail a été de vérifier s'il pouvait également participer à l'activation transciptionnelle ainsi que de caractériser les bases moléculaires de cette activation transcriptionnelle. En utilisant le promoteur du gène de l'ADN polymérase acomme modèle d'étude, j'ai pu montrer que la stimulation d'un gène rapporteur sous le contrôle du promoteur de l'ADN polymérase a était corrélée à la liaison de CDPICux à l'ADN. De plus, pllO stimule l'expression de l'ADN polymérase a endogène. L'analyse séquentielle du promoteur de l'ADN polymérase a a permis l'identification d'un élément cis requis pour l'activation par pllO, mais sur lequel pllO ne se lie pas. J'ai déterminé qu'E2Fl et E2F2 coopèrent avec pllO pour activer le promoteur de l'ADN polymérase a, et ceci via cet élément cis. De plus, des expériences d'immunoprécipitation de chromatine ont révélé que CDPICux recrute les facteurs E2Fs sur le promoteur. Par des analyses de ChIP-chip, j'ai mis en évidence de nombreux gènes cibles communs à pllO et E2Fl. Parmi eux, les gènes impliqués dans le métabolisme de l'ADN et dans la progression du cycle cellulaire sont surreprésentés. Des études complémentaires ont montré que plI 0 et E2F coopèrent pour activer la plupart des gènes impliqués dans la progression du cycle cellulaire. J'ai par ailleurs décrit un second événement protéolytique, permettant d~ générer une isoforme ne possédant pas deux des domaines répresseurs actifs présents dans la région carboxy-terminale de la protéine. Ce clivage est seulement observé au cours de la phase S, et non lors de la phase G 1 précoce, suggérant qu'il a lieu dans les cellules en prolifération. J'ai déterminé que les caspases étaient responsables de ce clivage, et ceci de façon indépendante de l'apoptose. Une forme de CDPICux tronquée de sa région 111 carboxy-terminale représente un meilleur activateur des cibles impliquées dans le cycle cellulaire et accélère l'entrée des cellules Kit225 T en phase S, alors qu'une forme non­ clivable de plI 0 CDP/Cux est inactive dans ces deux essais. Ces derniers résultats ont identifié pllO CDP/Cux comme un substrat des caspases dans les cellules en prolifération, et suggèrent un mécanisme par lequel les caspases pourraient accélérer la progression du cycle cellulaire. IV Acknowledgements First, 1 would like to acknowledge my supervisor, Dr. Alain Nepveu for his guidance, encouragement, advice, and criticism throughout the course of my studies. 1 would like to thank my thesis advisory committee for their help: Dr. Mark Featherstone, Dr. Jacques Drouin, and Dr. John Mort 1 am grateful to CUITent and former members of Dr. Nepveu's laboratory for their advice and friendship: Marianne Santaguida, Lam Leduy, Ginette Bérubé, Hélène Gingras, Rachel Dudley, Laurent Sansregret, Charles Vadnais, Nishant Ramlal, Valérie Kédinger, Chantal Cadieux, Vi-Minh-Tri Su, Ryoko Harada, Rania Siam, Brigitte Goulet, Lélia Raynal, Oriana Muzzin, Nam Sung Moon, Adela Reid, Yelena Markovic, and Brian Wilson. 1 would also like to thank current and former members of the Molecular Oncology Group for scientific discussion, friendship and support, especially Jasmine Abella, Janelle Barry, Pascal Peschard, Nancy Dionne, Julia Brain, Melanie Frigault, Claire Tuason, Kelly Fathers, Hayley Mak, Christine Parachoniak, Nathalie Dourdin, Caroline Saucier, Lina Musallam, RafNotarmaso, and Anna Moriatis. 1 would like to ex tend my gratitude to Laurent Sansregret, Brigitte Goulet, Brian Wilson, Rachel Dudley, and Rebecca Pearce for proofreading my thesis. Thank you, Valérie Kédinger, for translating my abstract into French. 1 am grateful to the Fonds de Recherche en Santé du Québec, the National Cancer Institute (Terry Fox Foundation), the Royal Victoria Hospital Research Institute/McGill University Health Centre, and the McGill University Faculty of Medicine for financial support. 1 would like to say a special thank you to sorne women who have been good friends and raIe models: Oona Johnstone, Rebecca Pearce, Barbara Freedman, Robin Neilson, Jill Barker, Lisa Heggum, Alda Truscott and Nina Truscott. A heartfelt thanks also to Patrick Cafferty, Clarisse Kehler-Siebert, Mary Chamberlin, Jennifer Hassard, and Jason Baardsnes for their friendship. 1 would like to express my appreciation to Pascal Poulin for his love and support. My progress this far would not have been possible without my family - my parents Bill and Nina Truscott, my brother Mark, my sister-in-law Lisa Heggum, Mary Lou Lascelles, and last but not least, my grandmother, Agnia Elensky. Thank you for your love, encouragement, and continuous support. v Preface The guidelines conceming thesis preparation issued by the Faculty of Graduate and Postdoctoral Studies at McGill University reads as follows: 1.
Recommended publications
  • 5850.Full.Pdf
    Soluble NSF Attachment Protein Receptors (SNAREs) in RBL-2H3 Mast Cells: Functional Role of Syntaxin 4 in Exocytosis and Identification of a Vesicle-Associated This information is current as Membrane Protein 8-Containing Secretory of September 25, 2021. Compartment Fabienne Paumet, Joëlle Le Mao, Sophie Martin, Thierry Galli, Bernard David, Ulrich Blank and Michèle Roa Downloaded from J Immunol 2000; 164:5850-5857; ; doi: 10.4049/jimmunol.164.11.5850 http://www.jimmunol.org/content/164/11/5850 http://www.jimmunol.org/ References This article cites 60 articles, 36 of which you can access for free at: http://www.jimmunol.org/content/164/11/5850.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 25, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2000 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Soluble NSF Attachment Protein Receptors (SNAREs) in RBL-2H3 Mast Cells: Functional Role of Syntaxin 4 in Exocytosis and Identification of a Vesicle-Associated Membrane Protein 8-Containing Secretory Compartment1 Fabienne Paumet,* Joe¨lle Le Mao,* Sophie Martin,* Thierry Galli,† Bernard David,* Ulrich Blank,* and Miche`le Roa2* Mast cells upon stimulation through high affinity IgE receptors massively release inflammatory mediators by the fusion of spe- cialized secretory granules (related to lysosomes) with the plasma membrane.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Autophagy Suppresses Ras-Driven Epithelial Tumourigenesis by Limiting the Accumulation of Reactive Oxygen Species
    OPEN Oncogene (2017) 36, 5576–5592 www.nature.com/onc ORIGINAL ARTICLE Autophagy suppresses Ras-driven epithelial tumourigenesis by limiting the accumulation of reactive oxygen species This article has been corrected since Advance Online Publication and a corrigendum is also printed in this issue. J Manent1,2,3,4,5,12, S Banerjee2,3,4,5, R de Matos Simoes6, T Zoranovic7,13, C Mitsiades6, JM Penninger7, KJ Simpson4,5, PO Humbert3,5,8,9,10 and HE Richardson1,2,5,8,11 Activation of Ras signalling occurs in ~ 30% of human cancers; however, activated Ras alone is not sufficient for tumourigenesis. In a screen for tumour suppressors that cooperate with oncogenic Ras (RasV12)inDrosophila, we identified genes involved in the autophagy pathway. Bioinformatic analysis of human tumours revealed that several core autophagy genes, including GABARAP, correlate with oncogenic KRAS mutations and poor prognosis in human pancreatic cancer, supporting a potential tumour- suppressive effect of the pathway in Ras-driven human cancers. In Drosophila, we demonstrate that blocking autophagy at any step of the pathway enhances RasV12-driven epithelial tissue overgrowth via the accumulation of reactive oxygen species and activation of the Jun kinase stress response pathway. Blocking autophagy in RasV12 clones also results in non-cell-autonomous effects with autophagy, cell proliferation and caspase activation induced in adjacent wild-type cells. Our study has implications for understanding the interplay between perturbations in Ras signalling and autophagy in tumourigenesis,
    [Show full text]
  • Selective Expression of a SNARE-Cleaving Protease in Peripheral Sensory Neurons Attenuates Pain-Related Gene Transcription and Neuropeptide Release
    International Journal of Molecular Sciences Article Selective Expression of a SNARE-Cleaving Protease in Peripheral Sensory Neurons Attenuates Pain-Related Gene Transcription and Neuropeptide Release Wanzhi Wang 1, Miaomiao Kong 1, Yu Dou 1, Shanghai Xue 1, Yang Liu 1, Yinghao Zhang 1, Weiwei Chen 1, Yanqing Li 1, Xiaolong Dai 1, Jianghui Meng 1,2,* and Jiafu Wang 1,2,* 1 School of Life Sciences, Henan University, Kaifeng 475001, China; [email protected] (W.W.); [email protected] (M.K.); [email protected] (Y.D.); [email protected] (S.X.); [email protected] (Y.L.); [email protected] (Y.Z.); [email protected] (W.C.); [email protected] (Y.L.); [email protected] (X.D.) 2 School of Biotechnology, Faculty of Science and Health, Dublin City University, Glasnevin, Dublin 9, Ireland * Correspondence: [email protected] (J.M.); [email protected] (J.W.) Abstract: Chronic pain is a leading health and socioeconomic problem and an unmet need exists for long-lasting analgesics. SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) are required for neuropeptide release and noxious signal transducer surface trafficking, thus, selective expression of the SNARE-cleaving light-chain protease of botulinum neurotoxin A (LCA) in peripheral sensory neurons could alleviate chronic pain. However, a safety concern to Citation: Wang, W.; Kong, M.; this approach is the lack of a sensory neuronal promoter to prevent the expression of LCA in the Dou, Y.; Xue, S.; Liu, Y.; Zhang, Y.; central nervous system. Towards this, we exploit the unique characteristics of Pirt (phosphoinositide- Chen, W.; Li, Y.; Dai, X.; Meng, J.; et al.
    [Show full text]
  • Widespread Sequence Variations in VAMP1 Across Vertebrates Suggest a Potential Selective Pressure from Botulinum Neurotoxins
    Widespread Sequence Variations in VAMP1 across Vertebrates Suggest a Potential Selective Pressure from Botulinum Neurotoxins The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Peng, L., M. Adler, A. Demogines, A. Borrell, H. Liu, L. Tao, W. H. Tepp, et al. 2014. “Widespread Sequence Variations in VAMP1 across Vertebrates Suggest a Potential Selective Pressure from Botulinum Neurotoxins.” PLoS Pathogens 10 (7): e1004177. doi:10.1371/journal.ppat.1004177. http://dx.doi.org/10.1371/ journal.ppat.1004177. Published Version doi:10.1371/journal.ppat.1004177 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:12717507 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Widespread Sequence Variations in VAMP1 across Vertebrates Suggest a Potential Selective Pressure from Botulinum Neurotoxins Lisheng Peng1, Michael Adler2*, Ann Demogines3, Andrew Borrell2, Huisheng Liu4, Liang Tao1, William H. Tepp5, Su-Chun Zhang4, Eric A. Johnson5, Sara L. Sawyer3*, Min Dong1* 1 Department of Microbiology and Immunobiology, Harvard Medical School and Division of Neuroscience, New England Primate Research Center, Southborough, Massachusetts, United States of America, 2 Neurobehavioral Toxicology Branch, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen
    [Show full text]
  • VAMP1 Polyclonal Antibody Catalog Number:13115-1-AP 2 Publications
    For Research Use Only VAMP1 Polyclonal antibody Catalog Number:13115-1-AP 2 Publications www.ptglab.com Catalog Number: GenBank Accession Number: Purification Method: Basic Information 13115-1-AP BC023286 Antigen affinity purification Size: GeneID (NCBI): Recommended Dilutions: 150ul , Concentration: 500 μg/ml by 6843 WB 1:500-1:2000 Nanodrop and 213 μg/ml by Bradford Full Name: IF 1:20-1:200 method using BSA as the standard; vesicle-associated membrane protein Source: 1 (synaptobrevin 1) Rabbit Calculated MW: Isotype: 117 aa, 13 kDa IgG Observed MW: Immunogen Catalog Number: 13 kDa AG3787 Applications Tested Applications: Positive Controls: IF, WB,ELISA WB : human brain tissue, Cited Applications: IF : SH-SY5Y cells, WB Species Specificity: human, mouse, rat Cited Species: mouse, rat VAMP1, also named as synaptobrevin 1, is a member of the vesicle-associated membrane protein Background Information (VAMP)/synaptobrevin family. VAMP1 is a part of the SNARE (soluble NSF-attachment protein receptor) complex. Characterized by a common sequence called the SNARE motif, SNARE proteins are involved in membrane fusion and vesicular transport (PMID: 11252968). VAMP1 is involved in synaptic vesicle exocytosis, a fundamental step in neurotransmitter release. Notable Publications Author Pubmed ID Journal Application Hailei Yu 34116208 Pharmacol Res WB Xing-Lian Duan 31962145 Neuroscience WB Storage: Storage Store at -20°C. Stable for one year after shipment. Storage Buffer: PBS with 0.02% sodium azide and 50% glycerol pH 7.3. Aliquoting is unnecessary for -20ºC storage For technical support and original validation data for this product please contact: This product is exclusively available under Proteintech T: 1 (888) 4PTGLAB (1-888-478-4522) (toll free E: [email protected] Group brand and is not available to purchase from any in USA), or 1(312) 455-8498 (outside USA) W: ptglab.com other manufacturer.
    [Show full text]
  • CENTOGENE's Severe and Early Onset Disorder Gene List
    CENTOGENE’s severe and early onset disorder gene list USED IN PRENATAL WES ANALYSIS AND IDENTIFICATION OF “PATHOGENIC” AND “LIKELY PATHOGENIC” CENTOMD® VARIANTS IN NGS PRODUCTS The following gene list shows all genes assessed in prenatal WES tests or analysed for P/LP CentoMD® variants in NGS products after April 1st, 2020. For searching a single gene coverage, just use the search on www.centoportal.com AAAS, AARS1, AARS2, ABAT, ABCA12, ABCA3, ABCB11, ABCB4, ABCB7, ABCC6, ABCC8, ABCC9, ABCD1, ABCD4, ABHD12, ABHD5, ACACA, ACAD9, ACADM, ACADS, ACADVL, ACAN, ACAT1, ACE, ACO2, ACOX1, ACP5, ACSL4, ACTA1, ACTA2, ACTB, ACTG1, ACTL6B, ACTN2, ACVR2B, ACVRL1, ACY1, ADA, ADAM17, ADAMTS2, ADAMTSL2, ADAR, ADARB1, ADAT3, ADCY5, ADGRG1, ADGRG6, ADGRV1, ADK, ADNP, ADPRHL2, ADSL, AFF2, AFG3L2, AGA, AGK, AGL, AGPAT2, AGPS, AGRN, AGT, AGTPBP1, AGTR1, AGXT, AHCY, AHDC1, AHI1, AIFM1, AIMP1, AIPL1, AIRE, AK2, AKR1D1, AKT1, AKT2, AKT3, ALAD, ALDH18A1, ALDH1A3, ALDH3A2, ALDH4A1, ALDH5A1, ALDH6A1, ALDH7A1, ALDOA, ALDOB, ALG1, ALG11, ALG12, ALG13, ALG14, ALG2, ALG3, ALG6, ALG8, ALG9, ALMS1, ALOX12B, ALPL, ALS2, ALX3, ALX4, AMACR, AMER1, AMN, AMPD1, AMPD2, AMT, ANK2, ANK3, ANKH, ANKRD11, ANKS6, ANO10, ANO5, ANOS1, ANTXR1, ANTXR2, AP1B1, AP1S1, AP1S2, AP3B1, AP3B2, AP4B1, AP4E1, AP4M1, AP4S1, APC2, APTX, AR, ARCN1, ARFGEF2, ARG1, ARHGAP31, ARHGDIA, ARHGEF9, ARID1A, ARID1B, ARID2, ARL13B, ARL3, ARL6, ARL6IP1, ARMC4, ARMC9, ARSA, ARSB, ARSL, ARV1, ARX, ASAH1, ASCC1, ASH1L, ASL, ASNS, ASPA, ASPH, ASPM, ASS1, ASXL1, ASXL2, ASXL3, ATAD3A, ATCAY, ATIC, ATL1, ATM, ATOH7,
    [Show full text]
  • 11056.Full.Pdf
    11056 • The Journal of Neuroscience, October 10, 2007 • 27(41):11056–11064 Neurobiology of Disease Huntingtin-Interacting Protein 1 Influences Worm and Mouse Presynaptic Function and Protects Caenorhabditis elegans Neurons against Mutant Polyglutamine Toxicity J. Alex Parker,1,2 Martina Metzler,3 John Georgiou,4 Marilyne Mage,1,2 John C. Roder,4,5 Ann M. Rose,6 Michael R. Hayden,3 and Christian Ne´ri1,2 1Inserm, Unit 857 “Neuronal Cell Biology and Pathology,” and 2University of Paris Rene´ Descartes, Equipe d’Accueil 4059, Centre Paul Broca, 75014 Paris, France, 3Centre for Molecular Medicine and Therapeutics, Child and Family Research Institute, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada V5Z 4H4, 4Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5, 5Department of Physiology, University of Toronto, Toronto, Ontario, Canada M5S 1A8, and 6Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3 Huntingtin-interacting protein 1 (HIP1) was identified through its interaction with htt (huntingtin), the Huntington’s disease (HD) protein. HIP1 is an endocytic protein that influences transport and function of AMPA and NMDA receptors in the brain. However, little is known about its contribution to neuronal dysfunction in HD. We report that the Caenorhabditis elegans HIP1 homolog hipr-1 modulates presynaptic activity and the abundance of synaptobrevin, a protein involved in synaptic vesicle fusion. Presynaptic function was also altered in hippocampal brain slices of HIP1 Ϫ/Ϫ mice dem- onstrating delayed recovery from synaptic depression and a reduction in paired-pulse facilitation, a form of presynaptic plasticity.
    [Show full text]
  • Starting a Molecular Systems View of Endocytosis
    ANRV356-CB24-20 ARI 3 September 2008 19:11 ANNUAL Protein Kinases: Starting REVIEWS Further Click here for quick links to Annual Reviews content online, a Molecular Systems View including: • Other articles in this volume of Endocytosis • Top cited articles • Top downloaded articles • Our comprehensive search Prisca Liberali, Pauli Ram¨ o,¨ and Lucas Pelkmans Institute of Molecular Systems Biology, ETH Zurich, CH-8093 Zurich, Switzerland; email: [email protected] Annu. Rev. Cell Dev. Biol. 2008. 24:501–23 Key Words First published online as a Review in Advance on membrane trafficking, phosphorylation, signal transduction, July 3, 2008 complexity, nonlinear systems, genetical physics The Annual Review of Cell and Developmental Biology is online at cellbio.annualreviews.org Abstract This article’s doi: The field of endocytosis is in strong need of formal biophysical model- 10.1146/annurev.cellbio.041008.145637 ing and mathematical analysis. At the same time, endocytosis must be Copyright c 2008 by Annual Reviews. much better integrated into cellular physiology to understand the for- by Universitat Zurich- Hauptbibliothek Irchel on 04/05/13. For personal use only. All rights reserved mer’s complex behavior in such a wide range of phenotypic variations. Annu. Rev. Cell Dev. Biol. 2008.24:501-523. Downloaded from www.annualreviews.org 1081-0706/08/1110-0501$20.00 Furthermore, the concept that endocytosis provides the space-time for signal transduction can now be experimentally addressed. In this review, we discuss these principles and argue for a systematic and top-down ap- proach to study the endocytic membrane system. We provide a summary of published observations on protein kinases regulating endocytic ma- chinery components and discuss global unbiased approaches to further map out kinase regulatory networks.
    [Show full text]
  • Gene Expression Analysis in the Parvalbuminimmunoreactive PV1 Nucleus of the Mouse Lateral Hypothalamus
    Published in (XURSHDQ-RXUQDORI1HXURVFLHQFH ± which should be cited to refer to this work. Gene expression analysis in the parvalbumin- immunoreactive PV1 nucleus of the mouse lateral hypothalamus F. Girard,1 Z. Meszar,1 C. Marti,1 F. P. Davis2 and M. Celio1 1Division of Anatomy and Program in Neuroscience, Universite´ de Fribourg, Route A. Gockel 1, CH1700 Fribourg, Switzerland 2Janelia Farm Research Campus, Howard Hughes Medical Institute, Ashburn, VA, USA Keywords: brain, calcium-binding protein, glutamate, lateral tuberal nucleus Abstract A solitary, elongated cluster of parvalbumin-immunoreactive neurons has been previously observed in the rodent ventrolateral hypothalamus. However, the function of this so-called PV1 nucleus is unknown. In this article, we report the results of an unbiased, broad and in-depth molecular characterization of this small, compact group of neurons. The Allen Brain Atlas database of in situ hybridization was screened in order to identify genes expressed in the PV1-nucleus-containing area of the hypothalamus, and those that might be co-expressed with parvalbumin. Although GABA is the principal neurotransmitter in parvalbumin-expressing cells in various other brain areas, we found that PV1 neurons express the vesicular glutamate transporter (VGlut) VGlut2-encoding gene Slc17a6 and are negative for the glutamic acid decarboxylase 1 (GAD1) gene. These cells also express the mRNA for the neuropeptides Adcyap1 and possibly Nxph4, express several types of potassium and sodium channels, are under the control of the neurotransmitter acetylcholine, bear receptors for the glial-derived neurotrophic factor, and produce an extracellular matrix rich in osteopontin. The PV1 nucleus is thus composed of glutamatergic nerve cells, expressing some typical markers of long-axon, projecting neurons (e.g.
    [Show full text]
  • Membrane Trafficking in Health and Disease Rebecca Yarwood*, John Hellicar*, Philip G
    © 2020. Published by The Company of Biologists Ltd | Disease Models & Mechanisms (2020) 13, dmm043448. doi:10.1242/dmm.043448 AT A GLANCE Membrane trafficking in health and disease Rebecca Yarwood*, John Hellicar*, Philip G. Woodman‡ and Martin Lowe‡ ABSTRACT KEY WORDS: Disease, Endocytic pathway, Genetic disorder, Membrane traffic, Secretory pathway, Vesicle Membrane trafficking pathways are essential for the viability and growth of cells, and play a major role in the interaction of cells with Introduction their environment. In this At a Glance article and accompanying Membrane trafficking pathways are essential for cells to maintain poster, we outline the major cellular trafficking pathways and discuss critical functions, to grow, and to accommodate to their chemical how defects in the function of the molecular machinery that mediates and physical environment. Membrane flux through these pathways this transport lead to various diseases in humans. We also briefly is high, and in specialised cells in some tissues can be enormous. discuss possible therapeutic approaches that may be used in the For example, pancreatic acinar cells synthesise and secrete amylase, future treatment of trafficking-based disorders. one of the many enzymes they produce, at a rate of approximately 0.5% of cellular protein mass per hour (Allfrey et al., 1953), while in Schwann cells, the rate of membrane protein export must correlate School of Biological Sciences, Faculty of Biology, Medicine and Health, with the several thousand-fold expansion of the cell surface that University of Manchester, Manchester, M13 9PT, UK. occurs during myelination (Pereira et al., 2012). The population of *These authors contributed equally to this work cell surface proteins is constantly monitored and modified via the ‡Authors for correspondence ([email protected]; endocytic pathway.
    [Show full text]
  • Downregulation of Carnitine Acyl-Carnitine Translocase by Mirnas
    Page 1 of 288 Diabetes 1 Downregulation of Carnitine acyl-carnitine translocase by miRNAs 132 and 212 amplifies glucose-stimulated insulin secretion Mufaddal S. Soni1, Mary E. Rabaglia1, Sushant Bhatnagar1, Jin Shang2, Olga Ilkayeva3, Randall Mynatt4, Yun-Ping Zhou2, Eric E. Schadt6, Nancy A.Thornberry2, Deborah M. Muoio5, Mark P. Keller1 and Alan D. Attie1 From the 1Department of Biochemistry, University of Wisconsin, Madison, Wisconsin; 2Department of Metabolic Disorders-Diabetes, Merck Research Laboratories, Rahway, New Jersey; 3Sarah W. Stedman Nutrition and Metabolism Center, Duke Institute of Molecular Physiology, 5Departments of Medicine and Pharmacology and Cancer Biology, Durham, North Carolina. 4Pennington Biomedical Research Center, Louisiana State University system, Baton Rouge, Louisiana; 6Institute for Genomics and Multiscale Biology, Mount Sinai School of Medicine, New York, New York. Corresponding author Alan D. Attie, 543A Biochemistry Addition, 433 Babcock Drive, Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin, (608) 262-1372 (Ph), (608) 263-9608 (fax), [email protected]. Running Title: Fatty acyl-carnitines enhance insulin secretion Abstract word count: 163 Main text Word count: 3960 Number of tables: 0 Number of figures: 5 Diabetes Publish Ahead of Print, published online June 26, 2014 Diabetes Page 2 of 288 2 ABSTRACT We previously demonstrated that micro-RNAs 132 and 212 are differentially upregulated in response to obesity in two mouse strains that differ in their susceptibility to obesity-induced diabetes. Here we show the overexpression of micro-RNAs 132 and 212 enhances insulin secretion (IS) in response to glucose and other secretagogues including non-fuel stimuli. We determined that carnitine acyl-carnitine translocase (CACT, Slc25a20) is a direct target of these miRNAs.
    [Show full text]